EIM
DPLO

Essex Investment Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Essex Investment Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-15,642
Closed -$547K – 363
2016
Q2 		$547K Hold
15,642
– – 0.09% 222
2016
Q1 		$429K Sell
15,642
-2,125
-12% -$62.6K 0.07% 248
2015
Q4 		$608K Buy
+17,767
New +$554K 0.1% 215

Other funds holding DPLO

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Essex Investment Management's DPLO Position: Q3 2016 in Review

Essex Investment Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2016, closing a stake of 15,642 shares — an estimated $547K sold.

Essex Investment Management first reported a position in DPLO in Q4 2015 and held it in 3 quarters. The position peaked at $608K in Q4 2015. 185 funds tracked by Wall St. Rank hold DPLO as of Q3 2016.

  • Essex Investment Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2016 after selling out during the quarter.
  • Essex Investment Management sold 15,642 DIPLOMAT PHARMACY, INC. shares in Q3 2016, an estimated $547K.
  • Essex Investment Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and held it in 3 quarters.
  • Essex Investment Management's DIPLOMAT PHARMACY, INC. position peaked at $608K in Q4 2015.
  • 185 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2016.

Based on Essex Investment Management's 13F filing for Q3 2016, filed 1 Nov 2016.